Northwestern Mutual Wealth Management
AGRX

Northwestern Mutual Wealth Management’s Agile Therapeutics AGRX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1
Closed -$1K – 3298
2021
Q2 		$1K Buy
+1
New +$3.3K ﹤0.01% 2946
2017
Q3 		– Hold
0
– -$1K – 2304
2017
Q2 		– Hold
0
– – – 1979

Other funds holding AGRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northwestern Mutual Wealth Management's AGRX Position: Q3 2021 in Review

Northwestern Mutual Wealth Management sold out of Agile Therapeutics (AGRX) in Q3 2021, closing a stake of 1 share — an estimated $1K sold.

Northwestern Mutual Wealth Management first reported a position in AGRX in Q2 2021 and held it in 1 quarter. The position peaked at $1K in Q2 2021. 49 funds tracked by Wall St. Rank hold AGRX as of Q3 2021.

  • Northwestern Mutual Wealth Management reported no remaining Agile Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 1 Agile Therapeutics share in Q3 2021, an estimated $1K.
  • Northwestern Mutual Wealth Management first reported a position in Agile Therapeutics in Q2 2021 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's Agile Therapeutics position peaked at $1K in Q2 2021.
  • 49 funds tracked by Wall St. Rank held Agile Therapeutics as of Q3 2021.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2021, filed 15 Nov 2021.